Current concepts in orthostatic hypotension management

Current Hypertension Reports

Volumn 15, Issue 4, 2013, Pages 304-312

  Arnold, Amy C ^a   Shibao, Cyndya ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autonomic failure; Autonomic insufficiency; Elderly; Fludrocortisone; Hypertension; Midodrine; Neurogenic orthostatic hypotension; Orthostatic hypotension

Indexed keywords

ATOMOXETINE; FLUDROCORTISONE; MIDODRINE; OCTREOTIDE; PYRIDOSTIGMINE; YOHIMBINE;

ABDOMINAL PAIN; ARTICLE; AUTONOMIC DYSFUNCTION; BODY POSTURE; CAUSAL ATTRIBUTION; COMORBIDITY; DIARRHEA; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG POTENTIATION; DRUG SAFETY; GENETIC ASSOCIATION; HEADACHE; HEART FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOKALEMIA; HYPOTENSION; MANAGED CARE; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PATIENT ASSESSMENT; PATIENT EDUCATION; PATIENT SELECTION; POSTPRANDIAL HYPOTENSION; SALT INTAKE; SINGLE DRUG DOSE; TREATMENT OUTCOME;

AGING; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; HUMANS; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; SYNCOPE;

EID: 84880921952     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-013-0362-3     Document Type: Article

References (76)

1. Smith JJ, Porth CM, Erickson M. Hemodynamic response to the upright posture. J Clin Pharmacol. 1994;34:375-86.
2. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69-72.
3. Gupta V, Lipsitz LA. Orthostatic hypotension in the elderly: diagnosis and treatment. Am J Med. 2007;120:841-7.
4. Benvenuto LJ, Krakoff LR. Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease. Am J Hypertens. 2011;24:135-44.
5. Masaki KH, Schatz IJ, Burchfiel CM, et al. Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. Circulation. 1998;98:2290-5.
6. Rose KM, Eigenbrodt ML, Biga RL, et al. Orthostatic hypotension predicts mortality in middle-aged adults: the Atherosclerosis Risk In Communities (ARIC) Study. Circulation. 2006;114:630-6.
7. • Fedorowski A, Stavenow L, Hedblad B, et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project). Eur Heart J. 2010;31:85-91. This prospective study provides new information on the prevalence and determinants of OH in a middle aged community based population. Furthermore, individuals with OH had an increased risk for all-cause mortality and coronary events, which more strongly correlated to the decline in diastolic blood pressure with standing.
8. Eigenbrodt ML, Rose KM, Couper DJ, et al. Orthostatic hypotension as a risk factor for stroke: the atherosclerosis risk in communities (ARIC) study, 1987-1996. Stroke. 2000;31:2307-13.
9. •• Franceschini N, Rose KM, Astor BC, et al. Orthostatic hypotension and incident chronic kidney disease: the atherosclerosis risk in communities study. Hypertension. 2010;56:1054-9. This is the first report to show an association between OH at baseline and the risk for chronic kidney disease in middle aged community dwellers, particularly in blacks. These studies add to the list of adverse health outcomes associated with this condition.
10. Rutan GH, Hermanson B, Bild DE, et al. Orthostatic hypotension in older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Hypertension. 1992;19:508-19.
11. Shibao C, Grijalva CG, Raj SR, et al. Orthostatic hypotension-related hospitalizations in the United States. Am J Med. 2007;120:975-80.
12. Ha AD, Brown CH, York MK, Jankovic J. The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. Parkinsonism Relat Disord. 2011;17:625-8.
13. Bonuccelli U, Lucetti C, Del Dotto P, et al. Orthostatic hypotension in de novo Parkinson disease. Arch Neurol. 2003;60:1400-4.
14. Senard JM, Rai S, Lapeyre-Mestre M, et al. Prevalence of orthostatic hypotension in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997;63:584-9.
15. Allcock LM, Ullyart K, Kenny RA, Burn DJ. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 2004;75:1470-1.
16. Low PA, Benrud-Larson LM, Sletten DM, et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27:2942-7.
17. Ooi WL, Barrett S, Hossain M, et al. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA. 1997;277:1299-304.
18. Weiss A, Grossman E, Beloosesky Y, Grinblat J. Orthostatic hypotension in acute geriatric ward: is it a consistent finding? Arch Intern Med. 2002;162:2369-74.
19. Jonsson PV, Lipsitz LA, Kelley M, Koestner J. Hypotensive responses to common daily activities in institutionalized elderly. A potential risk for recurrent falls. Arch Intern Med. 1990;150:1518-24.
20. Diedrich A, Biaggioni I. Segmental orthostatic fluid shifts. Clin Auton Res. 2004;14:146-7.
21. Poon IO, Braun U. High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans. J Clin Pharm Ther. 2005;30:173-8.
22. Kamaruzzaman S, Watt H, Carson C, Ebrahim S. The association between orthostatic hypotension and medication use in the British Women's Heart and Health Study. Age Ageing. 2010;39:51-6.
23. Gribbin B, Pickering TG, Sleight P, Peto R. Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971;29:424-31.
24. Davy KP, Seals DR, Tanaka H. Augmented cardiopulmonary and integrative sympathetic baroreflexes but attenuated peripheral vasoconstriction with age. Hypertension. 1998;32:298-304.
25. Parikh SM, Diedrich A, Biaggioni I, Robertson D. The nature of the autonomic dysfunction in multiple system atrophy. J Neurol Sci. 2002;200:1-10.
26. Kaufmann H, Hague K, Perl D. Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure. Neurology. 2001;56:980-1.
27. Smit AA, Halliwill JR, Low PA, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure. J Physiol. 1999;519(Pt 1):1-10.
28. Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci. 2009;146:3-7.
29. •• Li H, Kem DC, Reim S, et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59:402-8. These studies identified agonistic autoantibodies to β2-adrenergic and M3-muscarinic receptors in patients with symptomatic OH. There was a significant increase in IgG-induced activation of these receptors in patients compared to controls. Furthermore, the application of autoantibodies isolated from OH patients resulted in dose-dependent vasodilation in in vitro rat arteriole assays. These findings suggest a new potential mechanism that may contribute to OH in some patients.
30. Yu X, Stavrakis S, Hill MA, et al. Autoantibody activation of beta-adrenergic and muscarinic receptors contributes to an " autoimmune" orthostatic hypotension. J Am Soc Hypertens. 2012;6:40-7.
31. Tabara Y, Kohara K, Miki T. Polymorphisms of genes encoding components of the sympathetic nervous system but not the renin-angiotensin system as risk factors for orthostatic hypotension. J Hypertens. 2002;20:651-6.
32. Pankow JS, Dunn DM, Hunt SC, et al. Further evidence of a quantitative trait locus on chromosome 18 influencing postural change in systolic blood pressure: the Hypertension Genetic Epidemiology Network (HyperGEN) Study. Am J Hypertens. 2005;18:672-8.
33. Luo F, Wang Y, Wang X, et al. A functional variant of NEDD4L is associated with hypertension, antihypertensive response, and orthostatic hypotension. Hypertension. 2009;54:796-801.
34. Fedorowski A, Franceschini N, Brody J, et al. Orthostatic hypotension and novel blood pressure-associated gene variants: Genetics of Postural Hemodynamics (GPH) Consortium. Eur Heart J. 2012;33:2331-41.
35. Stemberger S, Scholz SW, Singleton AB, Wenning GK. Genetic players in multiple system atrophy: unfolding the nature of the beast. Neurobiol Aging. 2011;32:1924-14.
36. Shibao C, Garland EM, Gamboa A, et al. PRNP M129V homozygosity in multiple system atrophy vs. Parkinson's disease. Clin Auton Res. 2008;18:13-9.
37. Biaggioni I, Hollister AS, Robertson D. Dopamine in dopamine-β- hydroxylase deficiency. N Engl J Med. 1987;314:1415-6.
38. Carlson JE. Assessment of orthostatic blood pressure: measurement technique and clinical applications. South Med J. 1999;92:167-73.
39. Gibbons CH, Freeman R. Delayed orthostatic hypotension: a frequent cause of orthostatic intolerance. Neurology. 2006;67:28-32.
40. Lahrmann H, Cortelli P, Hilz M, et al. EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol. 2006;13:930-6.
41. Low PA. Testing the autonomic nervous system. Semin Neurol. 2003;23:407-21.
42. Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012;41:587-94.
43. Krediet CT, van Lieshout JJ, Bogert LW, et al. Leg crossing improves orthostatic tolerance in healthy subjects: a placebo-controlled crossover study. Am J Physiol Heart Circ Physiol. 2006;291:H1768-72.
44. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res. 1993;3:57-65.
45. Smit AA, Wieling W, Fujimura J, et al. Use of lower abdominal compression to combat orthostatic hypotension in patients with autonomic dysfunction. Clin Auton Res. 2004;14:167-75.
46. Podoleanu C, Maggi R, Brignole M, et al. Lower limb and abdominal compression bandages prevent progressive orthostatic hypotension in elderly persons: a randomized single-blind controlled study. J Am Coll Cardiol. 2006;48:1425-32.
47. Jordan J, Shannon JR, Grogan E, et al. A potent pressor response elicited by drinking water. Lancet. 1999;353:723.
48. Jordan J. Effect of water drinking on sympathetic nervous activity and blood pressure. Curr Hypertens Rep. 2005;7:17-20.
49. Ten Harkel AD, van Lieshout JJ, Wieling W. Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med. 1992;232:139-45.
50. van Lieshout JJ, Ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res. 2000;10:35-42.
51. Shibao C, Lipsitz LA, Biaggioni I. ASH Position Paper: Evaluation and Treatment of Orthostatic Hypotension. J Clin Hypertens. 2013;15:147-53.
52. Shibao C, Raj SR, Gamboa A, et al. Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function. Hypertension. 2007;50:47-53.
53. Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37:215-20.
54. Shibao C, Okamoto LE, Gamboa A, et al. Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failure. Hypertension. 2010;56:847-51.
55. Jordan J, Shannon JR, Biaggioni I, et al. Contrasting actions of pressor agents in severe autonomic failure. Am J Med. 1998;105:116-24.
56. Singer W, Opfer-Gehrking TL, McPhee BR, et al. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry. 2003;74:1294-8.
57. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab. 1998;83:339-43.
58. Jordan J, Shannon JR, Diedrich A, et al. Water potentiates the pressor effect of ephedra alkaloids. Circulation. 2004;109:1823-5.
59. Okamoto LE, Shibao C, Gamboa A, et al. Synergistic effect of norepinephrine transporter blockade and alpha-2 antagonism on blood pressure in autonomic failure. Hypertension. 2012;59:650-6.
60. Lipsitz LA, Nyquist Jr RP, Wei JY, Rowe JW. Postprandial reduction in blood pressure in the elderly. N Engl J Med. 1983;309:81-3.
61. Mathias CJ. Postprandial hypotension. Pathophysiological mechanisms and clinical implications in different disorders. Hypertension. 1991;18:694-704.
62. Vloet LC, Pel-Little RE, Jansen PA, Jansen RW. High prevalence of postprandial and orthostatic hypotension among geriatric patients admitted to Dutch hospitals. J Gerontol A Biol Sci Med Sci. 2005;60:1271-7.
63. Robertson D, Wade D, Robertson RM. Postprandial alterations in cardiovascular hemodynamics in autonomic dysfunction states. Am J Cardiol. 1981;48:1048-52.
64. Onrot J, Goldberg MR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. N Engl J Med. 1985;313:549-54.
65. Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007;50:54-61.
66. Gangavati A, Hajjar I, Quach L, et al. Hypertension, orthostatic hypotension, and the risk of falls in a community-dwelling elderly population: the maintenance of balance, independent living, intellect, and zest in the elderly of Boston study. J Am Geriatr Soc. 2011;59:383-9.
67. • Valbusa F, Labat C, Salvi P, et al. Orthostatic hypotension in very old individuals living in nursing homes: the PARTAGE study. J Hypertens. 2012;30:53-60. This study examined the prevalance of OH in elderly persons living in nursing homes, and showed a positive association of this condition with arterial stiffness and cardiovascular and metabolic comorbidities. Importantly, individuals with well controlled blood pressure exhibited a lower prevalence of OH, providing rationale for the use of antihypertensive therapy in elderly persons with comorbid hypertension.
68. Lipsitz LA, Gagnon M, Vyas M, et al. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005;45:216-21.
69. Biaggioni I, Robertson RM. Hypertension in orthostatic hypotension and autonomic dysfunction. Cardiol Clin. 2002;20:291-301. vii.
70. Goldstein DS, Pechnik S, Holmes C, et al. Association between supine hypertension and orthostatic hypotension in autonomic failure. Hypertension. 2003;42:136-42.
71. Arnold AC, Biaggioni I. Management approaches to hypertension in autonomic failure. Curr Opin Nephrol Hypertens. 2012;21:481-5.
72. Okamoto LE, Gamboa A, Shibao C, et al. Nocturnal blood pressure dipping in the hypertension of autonomic failure. Hypertension. 2009;53:363-9.
73. 1 blockers for the treatment of supine hypertension in autonomic failure.
74. Jordan J, Shannon JR, Pohar B, et al. Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol. 1999;10:35-42.
75. Gamboa A, Shibao C, Diedrich A, et al. Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure. Hypertension. 2008;51:1531-6.
76. Shibao C, Gamboa A, Abraham R, et al. Clonidine for the treatment of supine hypertension and pressure natriuresis in autonomic failure. Hypertension. 2006;47:522-6.